An Australian research team identified lymphatic precursors in the developing and young adult retina and choroid that may provide a better understanding of blood vessels and immune responses and the interaction of the immune system in retinal disease.
Author: OphthalmologyWeb
Why The Eye Is Better Than A Camera At Capturing Contrast And Faint Detail Simultaneously
The human eye long ago solved a problem common to both digital and film cameras: how to get good contrast in an image while also capturing faint detail.
Cataract Lens Study May Lead To Early Alzheimer’s Detection And Diagnosis
The results of a study by a team of U.S. researchers suggest that zinc found in lenses in individuals with Alzheimer’s disease as well a Down syndrome strongly supports the hypothesis that Alzheimer’s is a systemic disorder. Researchers are presenting …
New Study Finds Zinc Supplements May Help Prevent Age Related Macular Degeneration
A study conducted by an international team of researchers shows that oral zinc supplements may cause gene expression changes in the eye that could prevent age related macular degeneration. The research was presented this week at the 2011 Annual Meeting…
SAR 1118 Demonstrates Encouraging Results In Phase 2 Study Of Dry Eye Disease
SARcode Corporation presented data today for their lead investigational molecule, SAR 1118. In a Phase 2 dry eye trial, subjects receiving SAR 1118 demonstrated a reduction in corneal staining, increased tear production, and improved visual-related fun…
Second Sight Announces Significant Results From The Argus? II Retinal Prosthesis Trial At The ARVO 2011 Annual Meeting
Exciting results from the Argus? II Retinal Prosthesis System (‘Argus II’) clinical trial were presented today at the Association for Research in Vision and Ophthalmology, Inc. (ARVO) 2011 Annual Meeting. The clinical trial included 30 subjects implant…
LCA-Vision Announces Management Promotion
LCA-Vision Inc. , a leading provider of laser vision correction services under the LasikPlus® brand, announces the promotion of Marcello J. Celentano to the newly created position of Senior Vice President of Operations, effective May 1, 2011. In his n…
IRIDEX Granted U.S. Patent For Stepped Angled Laser Handpieces Used In Eye Surgery
MOUNTAIN VIEW, Calif., May 2, 2011 — IRIDEX Corporation (Nasdaq: IRIX) today
announced that the U.S. Patent and Trademark Office had issued to IRIDEX a patent
applying to a group of specially designed laser handpieces used in invasive ophthalmic
surgi…
Positive Ellex 2RT Data Demonstrates Efficacy In Treatment Of Early AMD
Adelaide, Australia, 3 May 2011 – Ellex Medical Lasers Limited (ASX:ELX), a global leader in ophthalmic technology, today announced milestone clinical results for its breakthrough Retinal Regeneration Therapy (Ellex 2RTT) for the treatment of Early Age…
Higher BMI In Children Associated With More Rapid Progression Of Diabetic Retinopathy
Overweight or obese children with type 1 diabetes developed diabetic retinopathy more quickly than their leaner counterparts, according to a poster here.
Merck’s Investigational Prostaglandin Analogue Ophthalmic Medication Tafluprost Meets Primary Endpoint In Phase III Study
WHITEHOUSE STATION, N.J., May 2, 2011 – Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that new Phase III data showed that patients with open-angle glaucoma or ocular hypertension, who were dosed once-daily with t…
Jackson Laboratory Team Finds Genetic Clue To ’emergency’ Glaucoma
Bar Harbor, Maine — Jackson Laboratory researchers and their collaborators have reported their discovery of a gene implicated in an acute and severe form of glaucoma known as angle-closure glaucoma (ACG). The gene’s activity points to previously unsus…
Pennsylvania Association For The Blind: Eye Examinations And Professionals
Regardless of your age or physical health, it’s important to have regular eye exams. Your doctor does more than determine if you need a prescription for glasses or contact lenses. Your exam will include a check for diseases such as glaucoma, macular de…
Pennsylvania Association For The Blind: Eye Examinations And Professionals
Regardless of your age or physical health, it’s important to have regular eye exams. Your doctor does more than determine if you need a prescription for glasses or contact lenses. Your exam will include a check for diseases such as glaucoma, macular de…
Local LASIK Firm To Replace Scouts’ Stolen Camping Gear
Boyscout Troop 153 of North Ridgeville, Ohio was facing the prospect of a whole summer without camping trips because their trailer and all of their camping equipment within was stolen.
Gene Therapy Shows Promise Against Age-Related Macular Degeneration
BOSTON (April 29, 2011) – A gene therapy approach using a protein called CD59, or protectin, shows promise in slowing the signs of age-related macular degeneration (AMD), according to a new in vivo study by researchers at Tufts University School of Med…
Cleveland Clinic-Led Study Finds Bevacizumab As Effective As FDA-Approved Ranibizumab In Treating Macular Degeneration
A new study published online today in The New England Journal of Medicine (NEJM) shows bevacizumab (Avastin) is as effective as ranibizumab (Lucentis), the current Food and Drug Administration-approved drug for treating age-related macular degeneration…
STAAR Surgical’s NanoFLEX™ Collamer® IOL Receives CE Mark Approval
STAAR Surgical Company , a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced CE Mark approval for its nanoFLEXT Collamer® Single Piece IOL which can be injected through a 2.2 mm incision with the n…
STAAR Surgical’s NanoFLEX™ Collamer® IOL Receives CE Mark Approval
STAAR Surgical Company , a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced CE Mark approval for its nanoFLEXT Collamer® Single Piece IOL which can be injected through a 2.2 mm incision with the n…
Sequenom Announces Publication Acceptance Of Manuscript From Age-Related Macular Degeneration Validation Study
Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced the acceptance for publication of the manuscript, “Clinical Validation of a Genetic Model to Estimate the Risk of Developing Choroid…